Fortgeschrittene und terminale Herzinsuffizienz im Lichte aktueller Leitlinien und innovativer Behandlungsoptionen

Schlüsselwörter

schwere Herzinsuffizienz - INTERMACS-Klassifikation - Eisentherapie - perkutane Mitralklappenrekonstruktion - mechanische Kreislaufunterstützung

Keywords

advanced heart failure - INTERMACS classification - iron supplementation - percutaneous mitral valve reconstruction - mechanical assist systems

• Literatur

• 1 Aaronson KD et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125: 3191-3200
• 2 Anker SD et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448
• 3 Costanzo MR et al. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Cardiac Fail 2010; 16: 277-284
• 4 Dandel M et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008; 118 (Suppl. 01) S94-S105
• 5 Feldman T et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364: 1395-1406
• 6 Franzen O et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011; 13: 569-576
• 7 Kirklin JK et al. The Fourth INTERMACS Annual Report: 4,000 Implants and Counting. J Heart Lung Transplant 2012; 31: 117-126
• 8 McMurray JJV et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33: 1787-1847
• 9 Mebazaa A et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007; 297: 1883-91
• 10 Pleger ST et al. Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Amer J Cardiol 2011; 108: 1478-1482
• 11 Pleger ST et al. One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip(C) implantation. Eur J Heart Fail 2013; 15: 919-927
• 12 Rose EA et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443
• 13 Rossi A et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. Heart 2011; 97: 1675-1680
• 14 Silverberg DS et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. JACC 2000; 35: 1737-1744
• 15 Slaughter MS et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251
• 16 Slaughter MS et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2013; 32: 675-683
• 17 Swedberg K et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013; 368: 1210-1219
• 18 Tschierscke R, Katus HA, Raake PWJ. Erste „Advanced Heart Failure Unit“ am Herzzentrum der Universitätsklinik Heidelberg. Beispiel einer integrierten Versorgungsstruktur zur optimierten Behandlung der terminalen Herzinsuffizienz. Dtsch med Wochenschr 2013; 138: 603-606
• 19 Vahanian A et al. Guidelines on the management of valvular heart disease (Version 2012). Eur J Cardio-thorac Surg 2012; 42: S1-S44